By a News Reporter-Staff News Editor at Medical Letter on the CDC& FDA When the Food and Drug Administration approved the first drug for people with spinal muscular atrophy a year ago, clinicians finally had hope for improving the lives of patients with the rare debilitating muscular disease. They teamed up with colleagues at several other instit
By a News Reporter-Staff News Editor at VerticalNews Health& Science A concerted effort by Republicans in Congress to repeal and replace the Affordable Care Act hit a surprising road block earlier this year: strong pushback against cuts to Medicaid. According to new findings from researchers at the University of Chicago, Medicaid is now seen as a
PESHAWAR: The National Accountability Bureau has approved inquiry against Agency Surgeon of North Waziristan, FATA Secretariat and FATA Development Authority officers over corruption and misuse of powers. The Executive Board of the NAB Khyber Pakhtunkhwa met in Peshawar on Thursday with the director general in the chair. Inquiry was also approved..
Unjustly so, according to new research from Harvard Medical School. The newly published analysis led by Anupam Jena of Harvard Medical School's Department of Health Care Policy, used a "big data" approach, linking insurance claims from millions of doctor's visits with daily rainfall totals from thousands of National Oceanic and Atmospheric Administ
The data provided Thursday by the Centers for Medicare and Medicaid Services represent enrollment only in the 39 states that use the federal health-care marketplace HealthCare.gov to sign up for coverage. The remaining states and the District of Columbia run their own health exchanges, many of which have extended deadlines. This is fabulou
Aga Khan University Hospital in Nairobi has acquired an ultra-modern Positron Emission Tomography CT scanner and Cyclotron, a first in East and Central Africa. Aga Khan University Hospital continues to be at the front of the fight against non-communicable diseases through evidence-based medicine backed by res-earch, a team-based approach and modern
Aptose Biosciences, a clinical-stage biotechnology company, has announced that the US Food and Drug Administration has granted orphan drug designation to CG806, a highly potent pan-FLT3/pan-BTK inhibitor, for the treatment of patients with acute myeloid leukemia. We are pleased that the FDA has recognized the unique potential of CG806 to address AM
Atara Biotherapeutics, Inc., a leading off-the-shelf T-cell immunotherapy company developing novel treatments for patients with cancer, autoimmune and viral diseases, today announced that it received clearance from the U.S. Food and Drug Administration to initiate two Phase 3 clinical studies with tabelecleucel in patients with rituximab-refractory
The biotech sector rebounded in 2017, with the iShares NASDAQ Biotechnology Index rallying more than 21 percent. This follows an underwhelming performance in 2016, when the IBB lost 21.6 percent. Synergy Seeks Approval for Expanded Use Of Its Constipation Drug Company: Synergy Pharmaceuticals Inc Type of Application: Supplemental New Drug Applicati
-Avadel Pharmaceuticals plc, Avadel or the Company, today announced its 2018 corporate objectives and financial expectations, including the commercial launch of Noctiva and the anticipated filing of a New Drug Application for both FT218, a once-nightly formulation of sodium oxybate using Micropump, and its fourth Unapproved Marketed Drug product, A
Boryung Vigencell, an affiliate of Korean drug maker Boryung Pharmaceutical, said on Dec. 28 that the countrys regulator has approved its Investigational New Drug application to initiate phase 2 clinical trials of its T-cell immunotherapy. The company was able to create tumor-specific cytotoxic T-cells which play a vital role in the immune respon
CStone Pharmaceuticals Co., Ltd, today announced that an investigational new drug filing has been submitted to Human Research Ethics Committees of the Ashford Cancer Center in Australia for CS1002, an independently-developed investigational cytotoxic T-lymphocyte-associated protein-4 inhibitor. Frank Jiang, Chief Executive Officer of CStone...
Contract notice: Delivery of a new digitization system for mammography and conventional images for the needs of the diagnostic department in "kots bourgas" eood. Supply, Installation, Personnel training and commissioning, Including warranty service of a new digitization system for mammography and conventional imaging, For the needs of the diagnosti
Drug Regulatory Authority said Division of Pharmaceutical Evaluation and Registration, DRAP completing free the process of digital listing of all registered drugs and in this aspect a provisional database has been uploaded on the official website of DRAP. The Authority has initiated the process early in this year for computerization of decades old.
Following is the text of press note issued by Press Information Department. Drug Regulatory Authority said Division of Pharmaceutical Evaluation and Registration, DRAP completing free the process of digital listing of all registered drugs and in this aspect a provisional database has been uploaded on the official website of DRAP. The Authority has.
-Edge Therapeutics, Inc., a clinical-stage biotechnology company developing novel hospital-based therapies for the management of acute, life-threatening conditions, today announced that an independent Data Monitoring Committee recommended that the Phase 3 NEWTON 2 study of EG-1962 continue as planned based on the completion of a pre-planned futilit
Former Attorney General of Louisiana, Charles C. Foti, Jr., Esq., a partner at the law firm of Kahn Swick& Foti, LLC, announces that KSF has commenced an investigation into Endologix, Inc.. On August 2, 2016, the Company issued a press release in which CEO John McDermott touted the performance of one of its devices, the Nellix EndoVascular Aneurysm
Atara Biotherapeutics announces FDA clearance to initiate two Phase 3 clinical studies to evaluate tabelecleucel in patients with rituximab-refractory Epstein-Barr virus associated post-transplant lymphoproliferative disorder. Atara Biotherapeutics, Inc., an off-the-shelf T-cell immunotherapy company developing novel treatments for...
"Diabetes is the leading cause of lower limb amputations," said Binita Ashar, M.D., director of the division of surgical devices in FDA`s Center for Devices and Radiological Health. "The FDA is dedicated to making technologies available that can help improve the quality of life for those with chronic diseases. An estimated 30.3 million people in t
Albany, NY 12/29/2017 Immunoassay has become essential laboratory technique that can be used to measure concentration of different analytes. Some of the established brands in global immunoassay systems include ADVIA, UniCel DxI, IDS-iSYS, LUMINEX, Cobas Analyzer etc. among others. The global market for immunoassay systems is expected to be dr
Jubilant Life Sciences Ltd, an integrated global Pharmaceutical and Life Sciences Company, has announced that Jubilant Pharma Limited, a material wholly owned subsidiary of the Company, through one of its wholly owned subsidiaries, has received a Supplemental New Drug Application approval from USFDA for DRAXIMAGE DTPA powder for solution.
Last week, La Jolla Pharmaceutical Company received FDA approval for their low blood pressure injectible Giapreza. The intravenous injectible is used to raise blood pressure in adults with certain symptoms like sepsis, shock, and hypertension, but can also cause dangerous blood clots. In a 321 patient clinical trial Giapreza raised blood pressure a
Taxes and health care insurance reform are expected to be the big issues when the Idaho legislative session begins Monday, Jan. 8. Mary Souza, R- Coeur d'Alene. Idaho lawmakers will be dealing with changes to federal tax laws and President Donald Trump's removal of the individual mandate requirement as part of the Affordable Care Act, otherwise kno
By a News Reporter-Staff News Editor at Obesity, Fitness& Wellness Week Mallinckrodt plc, a leading global specialty pharmaceutical company, announced it has closed the acquisition of Ocera Therapeutics, a clinical stage biopharmaceutical company focused on the development and commercialization of novel therapeutics for orphan and other serious l
Medsol Clinical Research in Port Charlotte conducts studies and clinical trials to determine if a medication or a device is safe and effective prior to being approved by the U.S. Food and Drug Administration. It can take up to 12 years for a medication to obtain FDA approval in the United States, said Medsol owner Maria Vasconcelos, a registe